Clinical Evaluation of Giomer Based Injectable Resin Composite Versus Resin Modified Glass Ionomer in Class V Carious Cavities Over 18-months.
Launched by CAIRO UNIVERSITY · May 19, 2022
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
In this study, Class V carious lesions will be restored using two different restorative materials either Resin modified glass ionomer or Giomer based injectable resin composite. Patients will be assessed for medical and dental histories first. Then an examination of the patients will be done using visual inspection by using a dental mirror and probe. Eligible patients according to inclusion and exclusion criteria will be informed about all procedures with follow up time if they accept. Their signature on written informed consents will be obtained. Eligible participants will be randomly divi...
Gender
ALL
Eligibility criteria
- • Participant Inclusion Criteria
- • Age 18-60 years.
- • Co-operative patients approving to participate in the study.
- • Male or female patients.
- • Patients with good general health
- • Moderate or high caries risk patient
- • Teeth Inclusion Criteria
- • Cervical Class V carious lesions.
- • Pulp asymptomatic vital carious teeth.
- • Participant Exclusion Criteria
- • Systemic disease or severe medical complications.
- • Participants with a history of allergy to any component of restorations will be used in the study.
- • Lack of compliance
- • Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits
- • Teeth Exclusion Criteria
- • Presence of apical or periapical pathosis.
- • tooth mobility
- • Non-vital teeth.
- • Teeth with advanced periodontal diseases.
- • Teeth which need indirect restoration.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials